Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Correspondence to: Dr March
OBJECTIVE: To evaluate the efficacy of paracetamol and a non-steroidal
anti-inflammatory drug for symptom relief in osteoarthritis.
DESIGN: Double
blind, randomised, controlled trials in individual patients (n of 1 trials).
Three treatment cycles with two weeks' each of paracetamol (1 g twice daily) and
diclofenac (50 mg twice daily) prepared in identical gelatin capsules.
SETTING: General practices in metropolitan Sydney, Australia.
SUBJECTS: 25
patients (median age 64 years) with pain of osteoarthritis (median duration of
disease eight years) considered by their general practitioners to require
regular treatment. 20 were already taking non-steroidal anti-inflammatory drugs.
MAIN OUTCOME MEASURES: Diary of pain and stiffness, function, and side effects.
RESULTS: 15 patients completed the study, five withdrew early but had made a
therapeutic decision, and five dropped out very early. Results from 20 patients
were analysed. Several patterns of response evolved. Eight of the 20 patients
found no clear difference, symptoms being adequately controlled by paracetamol;
five indicated a clear preference for the non-steroidal anti-inflammatory drug;
two showed control of symptoms after their initial two weeks of the
non-steroidal anti-inflammatory drug which continued throughout subsequent
treatment changes; in five the non-steroidal anti-inflammatory drug may have
been better but neither agent gave satisfactory control. After three months nine
of the 20 patients had adequate symptom control with paracetamol alone.
CONCLUSIONS: Of 1 studies--that is, randomised trials in individual
patients--are clinically useful in deciding treatment in heterogeneous
conditions which require long term symptomatic relief. In osteoarthritis many
patients currently receiving or being considered for non-steroidal
anti-inflammatory drugs may achieve adequate control with paracetamol.
(Accepted 19 August 1994)